首页> 外国专利> Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles

Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles

机译:使用智能聚合物纳米粒子的水溶性差的药物的水分散性口服,肠胃外和局部制剂

摘要

Polymeric nanoparticles with a hydrophobic core and a hydrophilic shell areformed from: 1) N-isopropyl acrylamide (NIPAAM), at a molar ratio of about 50%to about 90%, and preferably 60% for specific delivery routes such as oral or parenteral;either water-soluble vinyl derivatives like vinylpyrolidone (VP) or vinylacetate (VA), or water insoluble vinyl derivatives like methyl methacrylate(MMA) or styrene (ST), at a molar ratio of about 10% to about 30%;, and acrylic acid(AA), at a molar ratio of about 10% to about 30%. The formed nanoparticles may beoptionally surface functional using reactive groups present in AA, includingPEGylation, or conjugation of moieties such as chemotherapeutics, contrastingagents, antibodies, radionucleides, ligands, and sugars, for diagnostic,therapeutic, and imaging purposes. The polymeric nanoparticles are preferablydispersed in aqueous solutions. The polymeric nanoparticles incorporate oneor more types of medicines or bioactive agents in the hydrophobic core; on occasion,the medicine or bioactive agent may be conjugated to the nanoparticle surfacevia reactive functional groups. The polymeric nanoparticles are capable ofdelivering the said medicines or bioactive agents through oral, parenteral,or topical routes. The polymeric nanoparticles allow poorly water soluble medicinesor bioactive agents, or those with poor oral bioavailability, to be formulatedin an aqueous solution, and enable their convenient delivery into the systemiccirculation.
机译:具有疏水核和亲水壳的聚合物纳米粒子是由以下物质形成:1)N-异丙基丙烯酰胺(NIPAAM),摩尔比约为50%对于特定的递送途径,例如口服或肠胃外,为约90%,优选为60%;水溶性乙烯基衍生物,例如乙烯基吡咯烷酮(VP)或乙烯基醋酸盐(VA)或水不溶性乙烯基衍生物,例如甲基丙烯酸甲酯(MMA)或苯乙烯(ST),摩尔比约为10%至30%;和丙烯酸(AA),其摩尔比为约10%至约30%。形成的纳米颗粒可以是使用AA中存在的反应性基团可选地进行表面官能化,包括聚乙二醇化或化学疗法等部分的结合试剂,抗体,放射性核素,配体和糖,用于诊断,治疗和成像目的。聚合物纳米颗粒优选为分散在水溶液中。聚合物纳米粒子结合了一种疏水核中有更多类型的药物或生物活性剂;不定期的,药物或生物活性剂可以结合到纳米颗粒表面通过反应性官能团。聚合纳米粒子能够通过口服,肠胃外,或主题路线。聚合物纳米颗粒可用于水溶性差的药物或生物活性剂,或口服生物利用度较差的制剂在水溶液中,并能方便地输送到全身循环。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号